Abiopharma

Director MURDOCH LACHLAN K 🟢 acquired 1.3K shares (3 derivative) of Fox Corp (FOX) Transaction Date: Mar 25, 2026 | Filing ID: 021507

(99% Neutral) CANTOR EQUITY PARTNERS I, INC. (CEPO) Announces Business Combination

Director Johnson Margaret L 🟢 acquired 70 shares (1 derivative) of Fox Corp (FOX) Transaction Date: Mar 25, 2026 | Filing ID: 021506

Weaver Robert S. 🟡 adjusted position in 1.1K shares (2 derivative) of NEXSTAR MEDIA GROUP, INC. (NXST) at $218.53 Transaction Date: Mar 24, 2026 | Filing ID: 000004

Director HERNANDEZ ROLAND A 🟢 acquired 126 shares (1 derivative) of Fox Corp (FOX) Transaction Date: Mar 25, 2026 | Filing ID: 021505

Register of shareholders

Ciongoli Adam G. 🟢 acquired 523 shares (4 derivative) of Fox Corp (FOX) Transaction Date: Mar 25, 2026 | Filing ID: 021503

BANK OF CHILE (BCH) Files Form 6-K

Director CAREY CHASE 🟢 acquired 126 shares (1 derivative) of Fox Corp (FOX) Transaction Date: Mar 25, 2026 | Filing ID: 021502

New Form 3 - CNFinance Holdings Ltd. <b>Filed:</b> 2026-03-26 <b>AccNo:</b> 0001213900-26-034980 <b>Size:</b> 3 KB

(30% Negative) DERMATA THERAPEUTICS, INC. (DRMAW) Reports Q1 2026 Financial Results

Director Burck William A 🟢 acquired 136 shares (1 derivative) of Fox Corp (FOX) Transaction Date: Mar 25, 2026 | Filing ID: 021501

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025

📋 Fundrise Real Estate Interval Fund, LLC (May be deemed an affiliate of the issuer) plans to sell 62K shares of Fundrise Innovation Fund, LLC (at $380.00 each, total $23.7M) Filed: Mar 26, 2026 | ID: 000028